Cargando…

Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy

Intensity-modulated radiation therapy (IMRT) has been used for high-accurate physical dose distribution sculpture and employed to modulate different dose levels into Gross Tumor Volume (GTV), Clinical Target Volume (CTV) and Planning Target Volume (PTV). GTV, CTV and PTV can be prescribed at differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yaru, Wang, Hui, Li, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801459/
https://www.ncbi.nlm.nih.gov/pubmed/35111666
http://dx.doi.org/10.3389/fonc.2021.764665
_version_ 1784642463838765056
author Pang, Yaru
Wang, Hui
Li, He
author_facet Pang, Yaru
Wang, Hui
Li, He
author_sort Pang, Yaru
collection PubMed
description Intensity-modulated radiation therapy (IMRT) has been used for high-accurate physical dose distribution sculpture and employed to modulate different dose levels into Gross Tumor Volume (GTV), Clinical Target Volume (CTV) and Planning Target Volume (PTV). GTV, CTV and PTV can be prescribed at different dose levels, however, there is an emphasis that their dose distributions need to be uniform, despite the fact that most types of tumour are heterogeneous. With traditional radiomics and artificial intelligence (AI) techniques, we can identify biological target volume from functional images against conventional GTV derived from anatomical imaging. Functional imaging, such as multi parameter MRI and PET can be used to implement dose painting, which allows us to achieve dose escalation by increasing doses in certain areas that are therapy-resistant in the GTV and reducing doses in less aggressive areas. In this review, we firstly discuss several quantitative functional imaging techniques including PET-CT and multi-parameter MRI. Furthermore, theoretical and experimental comparisons for dose painting by contours (DPBC) and dose painting by numbers (DPBN), along with outcome analysis after dose painting are provided. The state-of-the-art AI-based biomarker diagnosis techniques is reviewed. Finally, we conclude major challenges and future directions in AI-based biomarkers to improve cancer diagnosis and radiotherapy treatment.
format Online
Article
Text
id pubmed-8801459
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88014592022-02-01 Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy Pang, Yaru Wang, Hui Li, He Front Oncol Oncology Intensity-modulated radiation therapy (IMRT) has been used for high-accurate physical dose distribution sculpture and employed to modulate different dose levels into Gross Tumor Volume (GTV), Clinical Target Volume (CTV) and Planning Target Volume (PTV). GTV, CTV and PTV can be prescribed at different dose levels, however, there is an emphasis that their dose distributions need to be uniform, despite the fact that most types of tumour are heterogeneous. With traditional radiomics and artificial intelligence (AI) techniques, we can identify biological target volume from functional images against conventional GTV derived from anatomical imaging. Functional imaging, such as multi parameter MRI and PET can be used to implement dose painting, which allows us to achieve dose escalation by increasing doses in certain areas that are therapy-resistant in the GTV and reducing doses in less aggressive areas. In this review, we firstly discuss several quantitative functional imaging techniques including PET-CT and multi-parameter MRI. Furthermore, theoretical and experimental comparisons for dose painting by contours (DPBC) and dose painting by numbers (DPBN), along with outcome analysis after dose painting are provided. The state-of-the-art AI-based biomarker diagnosis techniques is reviewed. Finally, we conclude major challenges and future directions in AI-based biomarkers to improve cancer diagnosis and radiotherapy treatment. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8801459/ /pubmed/35111666 http://dx.doi.org/10.3389/fonc.2021.764665 Text en Copyright © 2022 Pang, Wang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Pang, Yaru
Wang, Hui
Li, He
Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
title Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
title_full Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
title_fullStr Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
title_full_unstemmed Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
title_short Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
title_sort medical imaging biomarker discovery and integration towards ai-based personalized radiotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801459/
https://www.ncbi.nlm.nih.gov/pubmed/35111666
http://dx.doi.org/10.3389/fonc.2021.764665
work_keys_str_mv AT pangyaru medicalimagingbiomarkerdiscoveryandintegrationtowardsaibasedpersonalizedradiotherapy
AT wanghui medicalimagingbiomarkerdiscoveryandintegrationtowardsaibasedpersonalizedradiotherapy
AT lihe medicalimagingbiomarkerdiscoveryandintegrationtowardsaibasedpersonalizedradiotherapy